Introduction
Depending to its etiology, thrombocytosis is divided into two main categories, primary (i.e., clonal thrombocytosis) or secondary thrombocytosis (i.e., reactive thrombocytosis) (1) . The most common cause of clonal thrombocytosis is essential thrombocythemia. The common causes of reactive thrombocytosis include iron deficiency, inflammatory conditions or infection, malignancy, splenectomy, and acute blood loss. Described here is a case of upper gastrointestinal bleeding in which thrombocytosis was far more apparent than that usually observed in similar cases and in which thrombocytosis subsided after the cessation of bleeding.
Case Report
On July 26, 2016, a 59-year-old man with recurrent upper abdominal pain for a week prior was seen at a local hospital. The man had a history of cigarette smoking. Routine blood tests revealed a white blood cell (WBC) count of 22. The man also tested negative for the JAK2 V617F mutation, the JAK2 (EXON12) N542-E543 and N542-E544 deficiency, the JAK2 (EXON12) gene K539L1/L2 mutation, the MPL (EXON10) W515K\A\L\R1\R2\S) mutation, the MPL (EXON10)
Summary
Reported here is a case of upper gastrointestinal bleeding secondary to a peptic ulcer involving an extremely high platelet count of 989 × 10 9 /L. Myeloproliferative neoplasms were ruled out on the basis of gene mutation testing and a bone marrow biopsy. After the cessation of index bleeding, the platelet count decreased markedly. Thus, reactive thrombocytosis was considered as a possibility. As of August 6, 2016, the man developed melena and fatigue. On August 9, 2016, he was transferred to this Department. On physical examination, the skin was pallid and the upper abdomen was tender without rebound. Laboratory tests revealed that the WBC count was 8.9 × 10 9 /L (normal range: 3.5-9.5 × 10 9 /L), the percentage of neutrophils was 80.6% (normal range: 40-75%), the RBC count was 2. 
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Discussion
Physicians need to differentiate the nature of thrombocythemia due to an extremely high PLT. Classic Philadelphia chromosome-negative MPNs include polycythemia vera, essential thrombocythemia, and primary myelofibrosis (2) . Once a patient has a sustained PLT of more than 450 × 10 9 /L, essential thrombocythemia should be suspected. Additionally, novel gene mutations greatly facilitate the diagnosis of essential thrombocythemia based on current evidence (2). In the current patient, clonal thrombocytosis was initially suspected. However, the current patient did not test positive for any MPN-related gene mutations. A profound increase in PLT subsided after upper gastrointestinal bleeding was appropriately diagnosed and treated. Thus, MPNs were ruled out in the current case.
According to Tefferi et al., reactive thrombocytosis is defined as: i) no history of chronic myeloproliferative disorders; ii) a condition associated with secondary thrombocytosis; and iii) PLT returns to its normal level once an acute condition subsides (3). The current patient met these criteria for reactive thrombocytosis.
Upper gastrointestinal bleeding is one of the most frequent and lethal gastrointestinal conditions (4, 5) . In patients with acute upper gastrointestinal bleeding, hematemesis and melena are key clinical symptoms, anemia is a key physical sign, and a lower Hb level is evident in laboratory results. Upper gastrointestinal endoscopy is the method of choice for identifying the source of upper gastrointestinal bleeding. A peptic ulcer is one of the most common sources of upper gastrointestinal bleeding. In the current patient, thrombocythemia was primarily secondary to upper gastrointestinal bleeding according to endoscopic findings.
The precise mechanism for upper gastrointestinal bleeding and reactive thrombocytosis remains unclear. In essential thrombocythemia, a PLT level of > 800-1,000 × 10 9 /L has been reported to be associated with a higher incidence of severe bleeding independent of the use of aspirin (6) . Some bleeding events in MPNs may be caused by the reported depletion of high-molecular weight von Willebrand factor multimers, i.e. acquired von Willebrand disease. This condition has been noted in 20% of patients with essential thrombocythemia and is associated with a higher risk of bleeding (7). In the current patient, however, thrombocytosis was primarily secondary to upper gastrointestinal bleeding, which was verified by endoscopy, and thrombocytosis subsided after the cessation of bleeding.
In conclusion, patients with upper gastrointestinal bleeding and an increased level of PLT should be carefully screened for reactive thrombocytosis.
